CLEC7A and colorectal carcinoma: Disease progression rates were relatively decreased in CRC patients with CLEC7A mutation(s), although the tendency was not statistically significant due to the small number of CRC patients with mutant CLEC7A in TCGA database (Supplementary Fig. 6a).